BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Boddum K, Hansen MH, Jennum PJ, Kornum BR. Cerebrospinal Fluid Hypocretin-1 (Orexin-A) Level Fluctuates with Season and Correlates with Day Length. PLoS One 2016;11:e0151288. [PMID: 27008404 DOI: 10.1371/journal.pone.0151288] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 2.7] [Reference Citation Analysis]
Number Citing Articles
1 Lonstein JS, Linning‐duffy K, Tang Y, Moody A, Yan L. Impact of daytime light intensity on the central orexin (hypocretin) system of a diurnal rodent ( Arvicanthis niloticus ). Eur J Neurosci 2021;54:4167-81. [DOI: 10.1111/ejn.15248] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Barloese M. Current Understanding of the Chronobiology of Cluster Headache and the Role of Sleep in Its Management. Nat Sci Sleep 2021;13:153-62. [PMID: 33603525 DOI: 10.2147/NSS.S278088] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Azeez IA, Del Gallo F, Cristino L, Bentivoglio M. Daily Fluctuation of Orexin Neuron Activity and Wiring: The Challenge of "Chronoconnectivity". Front Pharmacol 2018;9:1061. [PMID: 30319410 DOI: 10.3389/fphar.2018.01061] [Cited by in Crossref: 24] [Cited by in F6Publishing: 18] [Article Influence: 6.0] [Reference Citation Analysis]
4 Vallée A, Lecarpentier Y, Guillevin R, Vallée JN. Demyelination in Multiple Sclerosis: Reprogramming Energy Metabolism and Potential PPARγ Agonist Treatment Approaches. Int J Mol Sci 2018;19:E1212. [PMID: 29659554 DOI: 10.3390/ijms19041212] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 5.0] [Reference Citation Analysis]
5 Soler JE, Xiong H, Samad F, Manfredsson FP, Robison AJ, Núñez AA, Yan L. Orexin (hypocretin) mediates light-dependent fluctuation of hippocampal function in a diurnal rodent. Hippocampus 2021. [PMID: 34263969 DOI: 10.1002/hipo.23376] [Reference Citation Analysis]
6 Ayache SS, Chalah MA. Fatigue in multiple sclerosis – Insights into evaluation and management. Neurophysiologie Clinique/Clinical Neurophysiology 2017;47:139-71. [DOI: 10.1016/j.neucli.2017.02.004] [Cited by in Crossref: 53] [Cited by in F6Publishing: 46] [Article Influence: 10.6] [Reference Citation Analysis]
7 Meesters Y, Gordijn MC. Seasonal affective disorder, winter type: current insights and treatment options. Psychol Res Behav Manag 2016;9:317-27. [PMID: 27942239 DOI: 10.2147/PRBM.S114906] [Cited by in Crossref: 29] [Cited by in F6Publishing: 6] [Article Influence: 4.8] [Reference Citation Analysis]
8 Burfeind KG, Yadav V, Marks DL. Hypothalamic Dysfunction and Multiple Sclerosis: Implications for Fatigue and Weight Dysregulation. Curr Neurol Neurosci Rep 2016;16:98. [PMID: 27662896 DOI: 10.1007/s11910-016-0700-3] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 3.4] [Reference Citation Analysis]
9 Aguirre CC. Sleep deprivation: a mind-body approach. Current Opinion in Pulmonary Medicine 2016;22:583-8. [DOI: 10.1097/mcp.0000000000000323] [Cited by in Crossref: 12] [Article Influence: 2.0] [Reference Citation Analysis]
10 Sakai N, Matsumura M, Lin L, Mignot E, Nishino S. HPLC analysis of CSF hypocretin-1 in type 1 and 2 narcolepsy. Sci Rep 2019;9:477. [PMID: 30679597 DOI: 10.1038/s41598-018-36942-8] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 4.3] [Reference Citation Analysis]
11 Liu C, Xue Y, Liu MF, Wang Y, Chen L. Orexin and Parkinson's disease: A protective neuropeptide with therapeutic potential. Neurochem Int 2020;138:104754. [PMID: 32422324 DOI: 10.1016/j.neuint.2020.104754] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
12 Li SB, Nevárez N, Giardino WJ, de Lecea L. Optical probing of orexin/hypocretin receptor antagonists. Sleep 2018;41. [PMID: 30060151 DOI: 10.1093/sleep/zsy141] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
13 Ahmadi-soleimani SM, Mianbandi V, Azizi H, Azhdari-zarmehri H, Ghaemi-jandabi M, Abbasi-mazar A, Mohajer Y, Darana SP. Coregulation of sleep-pain physiological interplay by orexin system: An unprecedented review. Behavioural Brain Research 2020;391:112650. [DOI: 10.1016/j.bbr.2020.112650] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
14 Chalah MA, Ayache SS. Is there a link between inflammation and fatigue in multiple sclerosis? J Inflamm Res 2018;11:253-64. [PMID: 29922081 DOI: 10.2147/JIR.S167199] [Cited by in Crossref: 17] [Cited by in F6Publishing: 8] [Article Influence: 4.3] [Reference Citation Analysis]
15 Kumar S, Behl T, Sehgal A, Singh S, Sharma N, Bhatia S, Al-Harassi A, Abdel-Daim MM, Bungau S. Exploring the Role of Orexinergic Neurons in Parkinson's Disease. Neurotox Res 2021. [PMID: 34495449 DOI: 10.1007/s12640-021-00411-4] [Reference Citation Analysis]
16 Usuda M, Kodaira M, Ogawa Y, Kanbayashi T, Yanagisawa S, Sekijima Y. Fluctuating CSF hypocretin-1 levels in mild brain trauma-induced Kleine-Levin syndrome. J Neurol Sci 2018;391:10-1. [PMID: 30103953 DOI: 10.1016/j.jns.2018.05.011] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Adeghate E, Lotfy M, D'Souza C, Alseiari SM, Alsaadi AA, Qahtan SA. Hypocretin/orexin modulates body weight and the metabolism of glucose and insulin. Diabetes Metab Res Rev 2020;36:e3229. [PMID: 31655012 DOI: 10.1002/dmrr.3229] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
18 Liguori C. Orexin and Alzheimer’s Disease. In: Lawrence AJ, de Lecea L, editors. Behavioral Neuroscience of Orexin/Hypocretin. Cham: Springer International Publishing; 2017. pp. 305-22. [DOI: 10.1007/7854_2016_50] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 4.8] [Reference Citation Analysis]